cDNA microarray-based identification of genes and pathways associated with oxaliplatin resistance

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Cancer Chemotherapy and Pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00280-004-0819-9PMID 15378272
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neurotrophic factors in Huntington's disease.

  2004cited by this paper
• SAM Thresholding and False Discovery Rates for Detecting Differential Gene Expression in DNA Microarrays

  2003cited by this paper
• SOURCE: a unified genomic resource of functional annotations, ontologies, and gene expression data

  2003cited by this paper
• Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation.

  2002cited by this paper
• The cellular pharmacology of oxaliplatin resistance.

  2002cited by this paper
• The copper transporter CTR1 regulates cisplatin uptake in Saccharomyces cerevisiae.

  2002cited by this paper
• Cellular roles of DNA polymerase zeta and Rev1 protein.

  2002cited by this paper
• Particular aspects of platinum compounds used at present in cancer treatment.

  2002cited by this paper
• Drug specific resistance to oxaliplatin is associated with apoptosis defect in a cellular model of colon carcinoma

  2002cited by this paper
• Mutagenic activity of cisplatin in the lacZ plasmid‐based transgenic mouse model

  2002cited by this paper
• Cellular roles of DNA polymerase ζ and Rev1 protein

  2002cited by this paper
• Mitochondria in platinum resistant cells.

  2001cited by this paper
• Identification of gene clusters differentially expressed during the cellular injury responses (CIR) to cisplatin

  2001cited by this paper
• Oxaliplatin clinical activity: a review.

  2000cited by this paper
• The many faces of DNA polymerases: strategies for mutagenesis and for mutational avoidance.

  2000cited by this paper
• Bridging the gap: a family of novel DNA polymerases that replicate faulty DNA.

  1999cited by this paper
• Cluster analysis and display of genome-wide expression patterns.

  1998cited by this paper
• Oxaliplatin: a review of preclinical and clinical studies.

  1998cited by this paper
• Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel.

  1996cited by this paper
• In vitro cytotoxicity, protein binding, red blood cell partitioning, and biotransformation of oxaliplatin.

  1993cited by this paper
• In vitro mutational specificity of cisplatin in the human hypoxanthine guanine phosphoribosyltransferase gene.

  1992cited by this paper
• Mitochondrial defects in cis-diamminedichloroplatinum(II)-resistant human ovarian carcinoma cells.

  1992cited by this paper

• Oxaliplatin and its derivatives – An overview

  2023cites this paper
• Systematic Review of Comparative Transcriptomic Studies of Cellular Resistance to Genotoxic Stress.

  2023cites this paper
• Aldehyde Dehydrogenase 2 Family Member (ALDH2) Is a Therapeutic Index for Oxaliplatin Response on Colorectal Cancer Therapy with Dysfunction p53

  2022cites this paper
• Inhibition of Ataxia-Telangiectasia Mutated and RAD3-Related (ATR) Overcomes Oxaliplatin Resistance and Promotes Antitumor Immunity in Colorectal Cancer.

  2019cites this paper
• Chronic oxymatrine treatment induces resistance and epithelial-mesenchymal transition through targeting the long non-coding RNA MALAT1 in colorectal cancer cells

  2018cites this paper
• Overexpression of RALY promotes migration and predicts poor prognosis in hepatocellular carcinoma

  2018cites this paper
• A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress

  2017cites this paper
• Proteomic profiling reveals DNA damage, nucleolar and ribosomal stress are the main responses to oxaliplatin treatment in cancer cells.

  2017cites this paper
• A subset of platinum-containing chemotherapeutic agents kill cells by inducing ribosome biogenesis stress rather than by engaging a DNA damage response

  2017cites this paper
• Effect of chirality in platinum drugs

  2015cites this paper
• trans,cis,cis‐Bis(benzoato)dichlorido(cyclohexane‐1R,2R‐diamine)platinum(IV): a Prodrug Candidate for the Treatment of Oxaliplatin‐Refractory Colorectal Cancer

  2014cites this paper
• Oxaliplatin induces different cellular and molecular chemoresistance patterns in colorectal cancer cell lines of identical origins

  2013cites this paper
• Double siRNA-targeting of cIAP2 and LIVIN results in synergetic sensitization of HCT-116 cells to oxaliplatin treatment

  2013cites this paper
• Cell fusion promotes chemoresistance in metastatic colon carcinoma

  2013cites this paper
• Meta‐analysis of gene expression profiles associated with histological classification and survival in 829 ovarian cancer samples

  2012cites this paper
• A Head and Neck Cancer Tumor Response-Specific Gene Signature for Cisplatin, 5-Fluorouracil Induction Chemotherapy Fails with Added Taxanes

  2012cites this paper
• Enhanced expression of nuclear factor I/B in oxaliplatin‐resistant human cancer cell lines

  2011cites this paper
• NONO and RALY proteins are required for YB-1 oxaliplatin induced resistance in colon adenocarcinoma cell lines

  2011influential citation
• Diagnostik und Therapie des Ovarialkarzinoms

  2010cites this paper
• Pharmacogenomic approach for the identification of novel determinants of acquired resistance to oxaliplatin in colorectal cancer

  2009cites this paper
• Whole-Genome Analysis of Cancer

  2009cites this paper
• Oxaliplatin: pre-clinical perspectives on the mechanisms of action, response and resistance

  2009cites this paper
• Molecular Profile of Esophageal Cancer Patients in North East Region of India

  2009cites this paper
• Down-regulated expression of cytochrome P450 (CYP) involved in the development and progression of esophageal adenocarcinoma.

  2009cites this paper
• Overexpression of phosphoserine aminotransferase PSAT1 stimulates cell growth and increases chemoresistance of colon cancer cells

  2008cites this paper
• Gene-expression profiling in epithelial ovarian cancer

  2008cites this paper
• Prognostic microarray in ovarian cancer : toward patient-tailored therapy

  2008cites this paper
• Oligomicroarray-based primary study of gene expression profile changes in Barrett's esophagus

  2008cites this paper
• Estudi farmacogenòmic per a la identificació de gens implicats en la resposta i l'adquisició de resistència a oxaliplatí en el càncer colorrectal

  2008influential citation
• Gene expression profile of esophageal cancer in North East India by cDNA microarray analysis.

  2007cites this paper
• Characterization of a clonal isolate of an oxaliplatin resistant ovarian carcinoma cell line A2780/C10.

  2007cites this paper
• Functional analysis of the gene expression profiles of colorectal cancer cell lines in relation to oxaliplatin and cisplatin cytotoxicity.

  2007cites this paper
• A snapshot of microarray-generated gene expression signatures associated with ovarian carcinoma

  2007cites this paper
• Establishment and gene analysis of an oxaliplatin-resistant colon cancer cell line THC8307/L-OHP

  2007cites this paper
• Clinical application of oxaliplatin in epithelial ovarian cancer

  2006cites this paper
• [Oxaliplatin and ovarian cancer].

  2006cites this paper
• Molecular prognostic markers in ovarian cancer: toward patient‐tailored therapy

  2006cites this paper
• A biological question and a balanced (orthogonal) design: the ingredients to efficiently analyze two-color microarrays with Confirmatory Factor Analysis

  2006cites this paper
• Pharmacogenomic identification of novel determinants of response to chemotherapy in colon cancer.

  2006cites this paper
• Common and distinct gene expression patterns induced by the herbicides 2,4-dichlorophenoxyacetic acid, cinidon-ethyl and tribenuron-methyl in wheat.

  2006cites this paper
• Chronic Oxaliplatin Resistance Induces Epithelial-to-Mesenchymal Transition in Colorectal Cancer Cell Lines

  2006cites this paper
• Effect of cystathionine beta-synthase variant 844ins68bp and methylenetetrahydrofolate reductase A1298C polymorphisms in xenografts on 5-FU efficacy and doubling time.

  2006cites this paper
• Novel mechanisms of platinum drug resistance identified in cells selected for resistance to JM118 the active metabolite of satraplatin

  2006cites this paper
• Progress in ovarian cancer research: Proceedings of the 5th Biennial Ovarian Cancer Research Symposium

  2005cites this paper
• Drug resistance in ovarian cancer: the emerging importance of gene transcription and spatio-temporal regulation of resistance.

  2005cites this paper
• Suppression of hREV1 Expression Reduces the Rate at Which Human Ovarian Carcinoma Cells Acquire Resistance to Cisplatin

  2005cites this paper
• Clinical benefits of patient medication notebooks

  2005cites this paper
• Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells

  2005cites this paper
• Molecular prognostic markers in ovarian cancer: toward patient-tailored therapy

  2005cites this paper
• Gene expression profiling to characterize anticancer drug sensitivity.

  2005cites this paper
• Specific patterns of changes in wheat gene expression after treatment with three antifungal compounds

  2005cites this paper
• Current Awareness on Comparative and Functional Genomics

  2004cites this paper